ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
A Phase II Study of Paclitaxel plus Cisplatin Chemotherapy in an Unfavourable Group of Patients with Cancer of Unknown Primary Site
Japanese Journal of Clinical Oncology
◽
10.1093/jjco/hyh124
◽
2004
◽
Vol 34
(11)
◽
pp. 681-685
◽
Cited By ~ 26
Author(s):
Y. H. Park
Keyword(s):
Phase Ii
◽
Phase Ii Study
◽
Cancer Of Unknown Primary
◽
Primary Site
◽
Unknown Primary
◽
Unknown Primary Site
◽
Patients With Cancer
Download Full-text
Related Documents
Cited By
References
A multicentre phase II study of carboplatin and prolonged oral etoposide in the treatment of cancer of unknown primary site (CUPS)
British Journal of Cancer
◽
10.1038/bjc.1998.395
◽
1998
◽
Vol 77
(12)
◽
pp. 2376-2380
◽
Cited By ~ 23
Author(s):
E Warner
◽
R Goel
◽
J Chang
◽
W Chow
◽
S Verma
◽
...
Keyword(s):
Phase Ii
◽
Phase Ii Study
◽
Cancer Of Unknown Primary
◽
Primary Site
◽
Unknown Primary
◽
Oral Etoposide
◽
Unknown Primary Site
◽
Multicentre Phase
Download Full-text
A phase II study of cisplatin, etoposide and gemcitabine in an unfavourable group of patients with carcinoma of unknown primary site
Annals of Oncology
◽
10.1093/annonc/mdg361
◽
2003
◽
Vol 14
(9)
◽
pp. 1425-1429
◽
Cited By ~ 19
Author(s):
C. Balaña
◽
J.-L. Manzano
◽
I. Moreno
◽
B. Cirauqui
◽
A. Abad
◽
...
Keyword(s):
Phase Ii
◽
Phase Ii Study
◽
Primary Site
◽
Unknown Primary
◽
Unknown Primary Site
◽
Carcinoma Of Unknown Primary
Download Full-text
Combination Regimen with Carboplatin, Epirubicin and Etoposide in Metastatic Carcinomas of Unknown Primary Site: A Hellenic Co-Operative Oncology Group Phase II Study
Oncology
◽
10.1159/000011890
◽
1998
◽
Vol 55
(5)
◽
pp. 426-430
◽
Cited By ~ 23
Author(s):
Evangelos Briasoulis
◽
Nicholas Tsavaris
◽
George Fountzilas
◽
Athanasios Athanasiadis
◽
Paris Kosmidis
◽
...
Keyword(s):
Phase Ii
◽
Phase Ii Study
◽
Primary Site
◽
Unknown Primary
◽
Combination Regimen
◽
Unknown Primary Site
◽
Oncology Group
Download Full-text
P07.01 18F-fluordesoxyglucose positron emission tomography (FDG-PET) for the detection of the primary lesion in brain metastasis (BM) patients with cancer of unknown primary site (CUPS)
Neuro-Oncology
◽
10.1093/neuonc/now188.112
◽
2016
◽
Vol 18
(suppl_4)
◽
pp. iv33-iv33
Author(s):
F. Wolpert
◽
H. Leske
◽
A. S. Berghoff
◽
E. J. Rushing
◽
N. Andratschke
◽
...
Keyword(s):
Positron Emission Tomography
◽
Brain Metastasis
◽
Cancer Of Unknown Primary
◽
Primary Lesion
◽
Primary Site
◽
Emission Tomography
◽
Unknown Primary
◽
Unknown Primary Site
◽
Patients With Cancer
◽
Positron Emission
Download Full-text
Phase II study of epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) for carcinoma of unknown primary site
Annals of Oncology
◽
10.1023/a:1008311919633
◽
2000
◽
Vol 11
(7)
◽
pp. 883-884
◽
Cited By ~ 15
Author(s):
F.X. Parnis
◽
I.N. Olver
◽
D. Kotasek
◽
J. Norman
◽
A. Taylor
◽
...
Keyword(s):
Continuous Infusion
◽
Phase Ii
◽
Phase Ii Study
◽
Primary Site
◽
Unknown Primary
◽
Unknown Primary Site
◽
Carcinoma Of Unknown Primary
Download Full-text
Corrigendum to “Defining risk groups of patients with cancer of unknown primary site and cervical nodal metastases by F-18 fluorodeoxyglucose positron emission tomography and computed tomography imaging” [Kaohsiung J Med Sci 32 (08) (2016) 407–413]
The Kaohsiung Journal of Medical Sciences
◽
10.1016/j.kjms.2016.10.005
◽
2016
◽
Vol 32
(11)
◽
pp. 597
Author(s):
Yung-Yueh Su
◽
Shih-Hsin Chen
◽
Chia-Hsun Hsieh
◽
Chun-Ta Liao
◽
Chien-Yu Lin
◽
...
Keyword(s):
Risk Groups
◽
Cancer Of Unknown Primary
◽
Primary Site
◽
Emission Tomography
◽
Unknown Primary
◽
Unknown Primary Site
◽
Computed Tomography Imaging
◽
Tomography Imaging
◽
Patients With Cancer
◽
Positron Emission
Download Full-text
Phase II study of carboplatin (CBDCA) and irinotecan (CPT-11) for patients with cancer of unknown primary (CUP)
Journal of Clinical Oncology
◽
10.1200/jco.2008.26.15_suppl.13514
◽
2008
◽
Vol 26
(15_suppl)
◽
pp. 13514-13514
Author(s):
M. Ando
◽
K. Yonemori
◽
M. Yunokawa
◽
E. Nakano
◽
T. Kouno
◽
...
Keyword(s):
Phase Ii
◽
Phase Ii Study
◽
Cancer Of Unknown Primary
◽
Unknown Primary
◽
Patients With Cancer
Download Full-text
A randomised phase II study comparing capecitabine plus streptozocin with or without cisplatin in the treatment of unresectable or metastatic gastroentero-neuroendocrine tumours of the foregut, pancreatic neuroendocrine tumours and neuroendocrine tumours of unknown primary site
http://isrctn.org/>
◽
10.1186/isrctn35124268
◽
2012
◽
Author(s):
Pippa Corrie
Keyword(s):
Phase Ii
◽
Neuroendocrine Tumours
◽
Phase Ii Study
◽
Primary Site
◽
Unknown Primary
◽
Unknown Primary Site
◽
Pancreatic Neuroendocrine Tumours
Download Full-text
Paclitaxel, cisplatin and gemcitabine in treatment of carcinomas of unknown primary site, a phase II study
Acta Oncologica
◽
10.3109/02841860903544592
◽
2010
◽
Vol 49
(4)
◽
pp. 423-430
◽
Cited By ~ 11
Author(s):
Anne Kirstine Hundahl Møller
◽
Karen Damgaard Pedersen
◽
Anita Gothelf
◽
Gedske Daugaard
Keyword(s):
Phase Ii
◽
Phase Ii Study
◽
Primary Site
◽
Unknown Primary
◽
Unknown Primary Site
Download Full-text
New Prognostic Index to Predict Survival in Patients with Cancer of Unknown Primary Site with Unfavourable Prognosis
Clinical Oncology
◽
10.1016/j.clon.2008.09.007
◽
2009
◽
Vol 21
(1)
◽
pp. 43-48
◽
Cited By ~ 14
Author(s):
D. Trivanović
◽
M. Petkovic
◽
D. Stimac
Keyword(s):
Prognostic Index
◽
Cancer Of Unknown Primary
◽
Primary Site
◽
Unknown Primary
◽
Unknown Primary Site
◽
Patients With Cancer
◽
Unfavourable Prognosis
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close